The trajectory of the erectile dysfunction drug presents a intricate picture for investors. While the initial launch generated substantial gains, the expiration of its patent opened the door to off-brand versions, https://telebookmarks.com/story12259433/viagra-and-big-pharma-a-volatile-opportunity